$CLGN· SEC filing ·

CLGN Reports $73K Q1 Revenue, $2.9M OpEx, Initiates Strategic Alternatives Review

CollPlant Biotechnologies Ltd Ordinary Shares · Now $0.40

-3.9% in 1h after detection

Post-detection moves

1h
-3.9%
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS